Fast Track Breast Cancer Vaccine Funding
A new vaccine developed by immunologist Dr. Vincent Tuohy and researchers of The Cleveland Clinic has had a 100% success rate with preventing breast tumors in mice. Clinical trials for humans could begin as early as next year but the clinic estimates it need at least $6 million for stage I and $16 million to complete the trials. Please Urge Congress, pharmaceutical companies and foundations to actually fund vaccine research. So far thirty pharmaceutical companies and foundations have rejected the request for funding. Why. Why. Why. Dr. Tuohy has a proven track record of immunology successes. He believe breast cancer is completely preventable and getting closer to making this a reality. Please help The Cleveland Clinic get the funding they need to actually FIND A CURE.
Comment